Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea
· Delayed Price · Currency is KRW
60,700
-3,000 (-4.71%)
At close: Apr 28, 2026
Next Biomedical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 497,976 | 733,427 | 331,554 | - | - | - | |
| Market Cap Growth | 50.17% | 121.21% | - | - | - | - | |
| Enterprise Value | 468,690 | 714,251 | 316,300 | - | - | - | |
| Last Close Price | 60700.00 | 89400.00 | 41000.00 | - | - | - | |
| PE Ratio | - | - | 115.95 | - | - | - | |
| PS Ratio | 30.22 | 44.51 | 34.74 | - | - | - | |
| PB Ratio | 10.35 | 15.25 | 7.34 | - | - | - | |
| P/TBV Ratio | 10.42 | 15.35 | 7.39 | - | - | - | |
| P/OCF Ratio | 398.34 | 586.68 | - | - | - | - | |
| EV/Sales Ratio | 28.45 | 43.35 | 33.15 | - | - | - | |
| Debt / Equity Ratio | 0.16 | 0.16 | 0.24 | 0.70 | 0.56 | 6.25 | |
| Net Debt / Equity Ratio | -0.61 | -0.61 | -0.68 | -0.17 | -0.19 | 1.92 | |
| Net Debt / EBITDA Ratio | 145.67 | 145.67 | 9.95 | 0.58 | 0.71 | -1.49 | |
| Net Debt / FCF Ratio | 15.40 | 15.40 | 18.70 | 0.66 | 0.45 | -1.60 | |
| Asset Turnover | 0.28 | 0.28 | 0.22 | 0.16 | 0.08 | 0.07 | |
| Inventory Turnover | 1.79 | 1.79 | 1.60 | 1.37 | 1.61 | 1.83 | |
| Quick Ratio | 4.89 | 4.89 | 3.68 | 1.35 | 1.38 | 1.70 | |
| Current Ratio | 5.38 | 5.38 | 3.95 | 1.57 | 1.59 | 1.82 | |
| Return on Equity (ROE) | -0.67% | -0.67% | 9.28% | -41.64% | -46.30% | - | |
| Return on Assets (ROA) | -0.76% | -0.76% | -5.05% | -10.57% | -10.03% | -13.55% | |
| Return on Capital Employed (ROCE) | -1.40% | -1.40% | -7.60% | -28.70% | -27.30% | -26.10% | |
| Earnings Yield | -0.06% | -0.04% | 0.86% | - | - | - | |
| FCF Yield | -0.38% | -0.26% | -0.50% | - | - | - | |
| Buyback Yield / Dilution | -13.65% | -13.65% | -14.72% | -1.10% | -28.34% | -13.05% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.